arrow
S

Simone I. Richardson

University of Witwatersrand
H指数:22
被引数:1,722

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease
2026-01-070
OAAI
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity

来自人类HIV-1疫苗试验参与者的糖链反应性抗体显示出广泛的病原体交叉反应性

2025-11-010
PRE
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine

莫桑比克队列中接种1剂或2剂BBIBP-CorV疫苗后的混合免疫

2025-06-150
OAAI
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

15个实验室SARS-CoV-2抗原性的全球协作比较

2024-12-180
OAAI
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families
2024-09-181
OAAI
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity

在杂交免疫的背景下,SARS-CoV-2 BA.4/5感染比BA.1触发更多的交叉反应fc γ riiia信号传导和中和

2024-07-231
PRE
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
2023-11-093
OAAI
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells
2023-08-122
OAAI
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
2023-08-034
OAAI
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial

ChAdOx1 nCoV-19 (AZD1222) 疫苗和针对omicron BA.1和BA.4变体的杂交体液免疫在疫苗接种后6个月的持久性 (COV005): 一项随机1b-2a期试验的事后分析

2023-03-0114
OAAI
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor
2023-02-017
OAAI
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
2023-01-2128
OAAI
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
2023-01-018
OAAI
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants
2022-08-109
OAAI